These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


453 related items for PubMed ID: 30380957

  • 21. Hearing outcome does not depend on the interval of intratympanic steroid administration in idiopathic sudden sensorineural hearing loss.
    Suzuki H, Koizumi H, Ohkubo J, Hohchi N, Ikezaki S, Kitamura T.
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3101-7. PubMed ID: 26879994
    [Abstract] [Full Text] [Related]

  • 22. Comparison of two different intratympanic corticosteroid injection protocols as salvage treatments for idiopathic sudden sensorineural hearing loss.
    Andrianakis A, Moser U, Kiss P, Holzmeister C, Andrianakis D, Tomazic PV, Wolf A, Graupp M.
    Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):609-618. PubMed ID: 33591388
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of low-dose intratympanic dexamethasone as a salvage treatment for idiopathic sudden sensorineural hearing loss: the Modbury Hospital experience.
    Oue S, Jervis-Bardy J, Stepan L, Chong S, Shaw CK.
    J Laryngol Otol; 2014 Jul; 128 Suppl 2():S27-30. PubMed ID: 24460985
    [Abstract] [Full Text] [Related]

  • 24. The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss.
    Lee JB, Choi SJ, Park K, Park HY, Choo OS, Choung YH.
    Eur Arch Otorhinolaryngol; 2011 Jun; 268(6):833-9. PubMed ID: 21221620
    [Abstract] [Full Text] [Related]

  • 25. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.
    Gouveris H, Selivanova O, Mann W.
    Eur Arch Otorhinolaryngol; 2005 Feb; 262(2):131-4. PubMed ID: 15747106
    [Abstract] [Full Text] [Related]

  • 26. Comparison of Two Different Treatment Protocols Using Systemic and Intratympanic Steroids with and without Hyperbaric Oxygen Therapy in Patients with Severe to Profound Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Controlled Trial.
    Cho I, Lee HM, Choi SW, Kong SK, Lee IW, Goh EK, Oh SJ.
    Audiol Neurootol; 2018 Feb; 23(4):199-207. PubMed ID: 30380530
    [Abstract] [Full Text] [Related]

  • 27. High Dose of Intratympanic Steroids for Sudden Sensorineural Hearing Loss Salvage.
    Taha A, Shlamkovitch N, Abu-Eta R, Yeheskeli E, Muallem-Kalmovich L, Gavriel H, Pitaro J.
    Otol Neurotol; 2019 Oct; 40(9):1134-1138. PubMed ID: 31498293
    [Abstract] [Full Text] [Related]

  • 28. Salvage intratympanic steroid therapy for sudden sensorineural hearing loss: our real-life experience in 32 patients.
    Ringrose T, Biggs TC, Jones L, Yunus A, Onderková A, Amir-Ghasemi A, Osei-Lah V, Hilton J, Buckland J.
    J Laryngol Otol; 2022 Sep; 136(9):827-830. PubMed ID: 35018883
    [Abstract] [Full Text] [Related]

  • 29. [A prospective controlled study on the proper time of intratympanic steroid for profound sudden sensorineural hearing loss of total frequency type].
    Zhong SX, Zuo WQ, Zhang BY, Qian Y, Lei Y.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Nov 07; 53(11):806-810. PubMed ID: 30453397
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy.
    Suzuki H, Hashida K, Nguyen KH, Hohchi N, Katoh A, Koizumi H, Ohbuchi T.
    Laryngoscope; 2012 May 07; 122(5):1154-7. PubMed ID: 22447636
    [Abstract] [Full Text] [Related]

  • 31. Frequency-specific efficacy of intratympanic steroid on idiopathic sudden sensorineural hearing loss.
    Suzuki H, Ohbuchi T, Do BH, Nguyen TN, Wakasugi T, Ohkubo JI, Kitamura T.
    Acta Otolaryngol; 2020 Sep 07; 140(9):756-760. PubMed ID: 32493084
    [Abstract] [Full Text] [Related]

  • 32. Management of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) Intratympanic Platelet-Rich Plasma (PRP) Versus Intratympanic Steroid Injections: A Cross-Sectional Study.
    Shawky M.
    Otolaryngol Pol; 2024 Jun 30; 78(3):1-6. PubMed ID: 38808642
    [Abstract] [Full Text] [Related]

  • 33. Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexamethasone.
    Hobson CE, Alexander TH, Harris JP.
    Curr Opin Otolaryngol Head Neck Surg; 2016 Oct 30; 24(5):407-12. PubMed ID: 27379547
    [Abstract] [Full Text] [Related]

  • 34. Systemic steroid versus combined systemic and intratympanic steroid treatment for sudden sensorineural hearing loss.
    Baysal E, Tunç O, Baglam T, Durucu C, Oz A, Karatas ZA, Polat M, Celenk F, Mumbuc S, Kanlikama M.
    J Craniofac Surg; 2013 Mar 30; 24(2):432-4. PubMed ID: 23524709
    [Abstract] [Full Text] [Related]

  • 35. The Impact of Intratympanic Steroid Dosage on Hearing Recovery in Sudden Sensorineural Hearing Loss.
    Nelson L, Swanson D, Borowiec E, Crossley J, Geng X, Cao X, Kim HJ, Hoa M.
    Ann Otol Rhinol Laryngol; 2023 Aug 30; 132(8):879-887. PubMed ID: 35993281
    [Abstract] [Full Text] [Related]

  • 36. The effect of intratympanic steroid injection frequency in idiopathic sudden sensorineural hearing loss.
    Sugihara EM, Evans MA, Neumann M, Babu SC.
    Am J Otolaryngol; 2018 Aug 30; 39(6):688-692. PubMed ID: 30076018
    [Abstract] [Full Text] [Related]

  • 37. [Intratympatic budesonide injection for treatment of refractorysudden sensorineural hearing loss].
    Sun RX, Zhao Y, Liu J.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun 20; 30(12):972-977. PubMed ID: 29771066
    [Abstract] [Full Text] [Related]

  • 38. Potential benefits of salvage intratympanic dexamethasone injection in profound idiopathic sudden sensorineural hearing loss.
    Choi JW, Lee CK, Kim SB, Lee DY, Ko SC, Park KH, Choi SJ.
    Eur Arch Otorhinolaryngol; 2020 Aug 20; 277(8):2219-2227. PubMed ID: 32296977
    [Abstract] [Full Text] [Related]

  • 39. Intratympanic Triamcinolone Acetonide as a Salvage Treatment for Idiopathic Sudden Sensorineural Hearing Loss.
    Andrianakis A, Moser U, Wolf A, Kiss P, Holzmeister C, Tomazic PV, Graupp M.
    Audiol Neurootol; 2021 Aug 20; 26(6):425-434. PubMed ID: 33789267
    [Abstract] [Full Text] [Related]

  • 40. Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss.
    Cvorovic L, Jovanovic MB, Milutinovic Z, Arsovic N, Djeric D.
    Otol Neurotol; 2013 Aug 20; 34(6):1021-6. PubMed ID: 23820795
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.